Polyreactive Monoclonal Autoantibodies in Multiple Sclerosis: Functional Selection from Phage Display Library and Characterization by Deep Sequencing Analysis

Cover Page
  • Authors: Lomakin Y.A.1, Zakharova M.Y.1, Belogurov A.A.1,2, Bykova N.A.3,4, Dronina M.A.1, Tupikin A.E.5,6, Knorre V.D.1, Boyko A.N.7,8, Favorov A.V.9,10,11, Kabilov M.R.5,6, Ponomarenko N.A.1, Gabibov A.G.1,2,12
  • Affiliations:
    1. Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences
    2. Institute of Gene Biology, Russian Academy of Sciences
    3. Kharkevich Institute for Information Transmission Problems
    4. Faculty of Bioengineering and Bioinformatics, Lomonosov Moscow State University
    5. Institute of Chemical Biology and Fundamental Medicine, Siberian Branch, Russian Academy of Sciences
    6. Genomics Core Facility, Siberian Branch, Russian Academy of Sciences
    7. Moscow Multiple Sclerosis Center at the City Hospital #11
    8. Pirogov Russian National Research Medical University, Department of Fundamental and Clinical Neurology and Neurosurgery
    9. Vavilov Institute of General Genetics, Russian Academy of Sciences
    10. Department of Oncology, Division of Biostatistics and Bioinformatics, Johns Hopkins University School of Medicine
    11. State Research Institute of Genetics and Selection of Industrial Microorganisms GosNIIGenetika
    12. Faculty of Chemistry, Lomonosov Moscow State University
  • Issue: Vol 5, No 4 (2013)
  • Pages: 94-104
  • Section: Research Articles
  • URL: https://actanaturae.ru/2075-8251/article/view/10580
  • DOI: https://doi.org/10.32607/20758251-2013-5-4-94-104
  • ID: 10580

Cite item

Full Text

Abstract

Multiple Sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system that primarily affects young and middle-aged people. It is widely accepted that B lymphocyte activation is required for MS progression. Despite the fact that the exact triggering mechanisms of MS remain enigmatic, one may suggest that MS can be induced by viral or bacterial infection in combination with specific genetic and environmental factors. Using deep sequencing and functional selection methodologies we characterized clones of poly- and cross-reactive antibodies that are capable of simultaneous recognition of viral proteins and autoantigens. The latter, in turn, possibly may trigger MS progression through molecular mimicry. It was identified that two cross-reactive antigens are probably recognized by light or heavy chains individually. According to the high structural homology between selected autoantibodies and a number of various antiviral IgGs, we suggest that a wide range of pathogens, instead of a single virus, be regarded as possible triggers of MS.

About the authors

Y. A. Lomakin

Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences

Author for correspondence.
Email: yasha.l@bk.ru
Russian Federation

M. Yu. Zakharova

Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences

Email: yasha.l@bk.ru
Russian Federation

A. A. Belogurov

Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences; Institute of Gene Biology, Russian Academy of Sciences

Email: yasha.l@bk.ru
Russian Federation

N. A. Bykova

Kharkevich Institute for Information Transmission Problems; Faculty of Bioengineering and Bioinformatics, Lomonosov Moscow State University

Email: yasha.l@bk.ru
Russian Federation

M. A. Dronina

Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences

Email: yasha.l@bk.ru
Russian Federation

A. E. Tupikin

Institute of Chemical Biology and Fundamental Medicine, Siberian Branch, Russian Academy of Sciences; Genomics Core Facility, Siberian Branch, Russian Academy of Sciences

Email: yasha.l@bk.ru
Russian Federation

V. D. Knorre

Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences

Email: yasha.l@bk.ru
Russian Federation

A. N. Boyko

Moscow Multiple Sclerosis Center at the City Hospital #11; Pirogov Russian National Research Medical University, Department of Fundamental and Clinical Neurology and Neurosurgery

Email: yasha.l@bk.ru
Russian Federation

A. V. Favorov

Vavilov Institute of General Genetics, Russian Academy of Sciences; Department of Oncology, Division of Biostatistics and Bioinformatics, Johns Hopkins University School of Medicine; State Research Institute of Genetics and Selection of Industrial Microorganisms GosNIIGenetika

Email: yasha.l@bk.ru
Russian Federation

M. R. Kabilov

Institute of Chemical Biology and Fundamental Medicine, Siberian Branch, Russian Academy of Sciences; Genomics Core Facility, Siberian Branch, Russian Academy of Sciences

Email: yasha.l@bk.ru
Russian Federation

N. A. Ponomarenko

Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences

Email: yasha.l@bk.ru
Russian Federation

A. G. Gabibov

Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences; Institute of Gene Biology, Russian Academy of Sciences; Faculty of Chemistry, Lomonosov Moscow State University

Email: yasha.l@bk.ru
Russian Federation

References

  1. Hauser S.L., Oksenberg J.R. // Neuron. 2006, V.52, №1, P.61-76
  2. Hemmer B., Nessler S., Zhou D., Kieseier B., Hartung H.P. // Nat. Clin. Practice Neurol. 2006, V.2, №4, P.201-211
  3. Compston A., Coles A. // Lancet. 2008, V.372, №9648, P.1502-1517
  4. Jersild C., Fog T., Hansen G.S., Thomsen M., Svejgaard A., Dupont B. // Lancet. 1973, V.2, №7840, P.1221-1225
  5. Barcellos L.F., Oksenberg J.R., Begovich A.B., Martin E.R., Schmidt S., Vittinghoff E., Goodin D.S., Pelletier D., Lincoln R.R., Bucher P. // Am. J. Hum. Genet. 2003, V.72, №3, P.710-716
  6. Marrosu M.G., Murru R., Murru M.R., Costa G., Zavattari P., Whalen M., Cocco E., Mancosu C., Schirru L., Solla E. // Human Molecular Genetics 2001, V.10, №25, P.2907-2916
  7. Dyment D.A., Herrera B.M., Cader M.Z., Willer C.J., Lincoln M.R., Sadovnick A.D., Risch N., Ebers G.C. // Human Molecular Genetics 2005, V.14, №14, P.2019-2026
  8. Masterman T., Ligers A., Olsson T., Andersson M., Olerup O., Hillert J. // Ann. Neurol. 2000, V.48, №2, P.211-219
  9. Barcellos L.F., Sawcer S., Ramsay P.P., Baranzini S.E., Thomson G., Briggs F., Cree B.C., Begovich A.B., Villoslada P., Montalban X. // Human Molecular Genetics 2006, V.15, №18, P.2813-2824
  10. Ramagopalan S.V., Morris A.P., Dyment D.A., Herrera B.M., DeLuca G.C., Lincoln M.R., Orton S.M., Chao M.J., Sadovnick A.D., Ebers G.C. // PLoS Genet. 2007, V.3, №9, P.1607-1613
  11. Robertson N.P., Fraser M., Deans J., Clayton D., Walker N., Compston D.A. // Brain. 1996, V.119, P.449-455
  12. Sadovnick A.D., Baird P.A., Ward R.H. // Am. J. Med. Genet. 1988, V.29, №3, P.533-541
  13. Willer C.J., Dyment D.A., Risch N.J., Sadovnick A.D., Ebers G.C. // Proc. Natl. Acad. Sci. USA. 2003, V.100, №22, P.12877-12882
  14. Ebers G.C., Sadovnick A.D., Dyment D.A., Yee I.M., Willer C.J., Risch N. // Lancet. 2004, V.363, №9423, P.1773-1774
  15. Sokolova E.A., Malkova N.A., Korobko D.S., Rozhdestvenskii A.S., Kakulya A.V., Khanokh E.V., Delov R.A., Platonov F.A., Popova T.Y., Aref’eva E.G. // PLoS One. 2013, V.8, №4, P.e61032
  16. Tsareva E.Yu., Kulakova O.G., Makarycheva O.Yu., Boyko A.N., Shchur S.G., Lashch N., Popova N.F., Gusev E.I., Bashinskaya V.V., Lvov D.V. // Mol Biol (Mosk). 2011, V.45, №6, P.886-893
  17. Yong V.W., Marks S. // Neurology. 2010, V.74, S1, P.S9-S16
  18. Lund F.E., Randall T.D. // Nat. Rev. Immunol. 2010, V.10, №4, P.236-247
  19. Ponomarenko N.A., Durova O.M., Vorobiev I.I., Aleksandrova E.S., Telegin G.B., Chamborant O.G., Sidorik L.L., Suchkov S.V., Alekberova Z.S., Gnuchev N.V. // J. Immunol. Meth. 2002, V.169, №1-2, P.197-211
  20. Ponomarenko N.A., Durova O.M., Vorobiev I.I., Belogurov A.A., Telegin G.B., Suchkov S.V., Misikov V.K., Morse H.C., Gabibov A.G. // Immunol. Lett. 2006, V.103, №1, P.45-50
  21. Ponomarenko N.A., Durova O.M., Vorobiev I.I., Belogurov A.A. Jr., Kurkova I.N., Petrenko A.G., Telegin G.B., Suchkov S.V., Kiselev S.L., Lagarkova M.A. // Proc. Natl. Acad. Sci. USA. 2006, V.103, №2, P.281-286
  22. Paty D.W., Li D.K. // Neurology. 1993, V.43, №4, P.662-667
  23. Sela M. // Rejuvenation Res. 2006, V.9, №1, P.126-133
  24. Stepanov A.V., Belogurov A.A. Jr., Ponomarenko N.A., Stremovskiy O.A., Kozlov L.V., Bichucher A.M., Dmitriev S.E., Smirnov I.V., Shamborant O.G., Balabashin D.S. // PLoS One. 2011, V.6, №6, P.e20991
  25. Belogurov A.A. Jr., Stepanov A.V., Smirnov I.V., Melamed D., Bacon A., Mamedov A.E., Boitsov V.M., Sashchenko L.P., Ponomarenko N.A., Sharanova S.N. // FASEB J. 2013, V.27, №1, P.222-231
  26. Gabibov A.G., Belogurov A.A. Jr., Lomakin Y.A., Zakharova M.Y., Avakyan M.E., Dubrovskaya V.V., Smirnov I.V., Ivanov A.S., Molnar A.A., Gurtsevitch V.E. // FASEB J. 2011, V.25, №12, P.4211-4221
  27. Wekerle H., Hohlfeld R. // N. Eng. J. Med. 2003, V.349, №2, P.185-186
  28. Lunemann J.D., Jelcic I., Roberts S., Lutterotti A., Tackenberg B., Martin R., Munz C. // J. Exp. Med. 2008, V.205, №8, P.1763-1773
  29. Chastain E.M., Miller S.D. // Immunol. Rev. 2012, V.245, №1, P.227-238
  30. Alamyar E., Giudicelli V., Li S., Duroux P., Lefranc M.P. // Immunome Res. 2012, V.8, №1, P.26
  31. Brochet X., Lefranc M.P., Giudicelli V. // Nucl. Acids Res. 2008. V. 36. P. W503–508. 2008, V.36, P.503-508
  32. Lefranc M.P., Giudicelli V., Ginestoux C., Jabado-Michaloud J., Folch G., Bellahcene F., Wu Y., Gemrot E., Brochet X., Lane J. // Nucl. Acids Res. 2009. V. 37. P. D1006–1012. 2009, V.37, P.1006-1012

Copyright (c) 2013 Lomakin Y.A., Zakharova M.Y., Belogurov A.A., Bykova N.A., Dronina M.A., Tupikin A.E., Knorre V.D., Boyko A.N., Favorov A.V., Kabilov M.R., Ponomarenko N.A., Gabibov A.G.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies